drugset / Trial / NCT00418509

Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers

NCT00418509

Phase 1 Completed 24 enrolled Novartis Schering-Plough · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study will compare the performance of three combination metered dose inhalation devices and the variability of mometasone and formoterol doses delivered to the lungs in a healthy volunteer population

Timeline

Start
2006-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified Inhaled
Subject Mometasone furoate Other / unclassified Inhaled

Indications

No indication recorded.